<code id='7AF6EEA81F'></code><style id='7AF6EEA81F'></style>
      • <acronym id='7AF6EEA81F'></acronym>
      <center id='7AF6EEA81F'><center id='7AF6EEA81F'><tfoot id='7AF6EEA81F'></tfoot></center><abbr id='7AF6EEA81F'><dir id='7AF6EEA81F'><tfoot id='7AF6EEA81F'></tfoot><noframes id='7AF6EEA81F'>
      • <optgroup id='7AF6EEA81F'><strike id='7AF6EEA81F'><sup id='7AF6EEA81F'></sup></strike><code id='7AF6EEA81F'></code></optgroup>
        5. <b id='7AF6EEA81F'><label id='7AF6EEA81F'><select id='7AF6EEA81F'><dt id='7AF6EEA81F'><span id='7AF6EEA81F'></span></dt></select></label></b><u id='7AF6EEA81F'></u>
          <i id='7AF6EEA81F'><strike id='7AF6EEA81F'><tt id='7AF6EEA81F'><pre id='7AF6EEA81F'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / knowledge / focus      
           
     
           
      
          focus 
           
      
           
      
           
       2025-08-04 05:23:03 
   
      
           
      
           
                        
          focus  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：61498
                                  
                                    
          
                                   
          Good CEOs 2022
          Hyacinth Empinado/STAT
          It’s that time of the year again when I recognize the Best Biopharma CEO of the year.
          This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.
          advertisement
          What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          New case study details death in closely watched Alzhiemer's trial
                                
                            
          Next article：  
                                      
                                          Medical leaders decry Supreme Court decision on affirmative action
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles